PRAGUE, March 24 (Reuters) - Zentiva ZNTVsp.PR has applied to delist its shares from the Prague Stock Exchange, it said on Tuesday, a month after French drug company Sanofi-Aventis (SASY.PA) succeeded in a buyout of the Czech generics maker.
Zentiva said the delisting should take effect from April 28. In a separate filing, it said it intended to withdraw global depositary shares traded in London.
Zentiva’s board decided to initiate the delisting earlier this month.
Sanofi raised its stake in Zentiva to 96.8 percent from 24.9 percent in a deal that valued the company at 43.9 billion crowns ($2.23 billion). (Reporting by Jason Hovet, editing by Will Waterman)